Search - tctmd.com

Displaying 461 - 480 of 648

Sort: Relevancy | Date

News Features

Denervación Renal 2.0: Marcando el Camino de la Recuperación Tras el Symplicity HTN-3

June 24, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Industry News

Edwards Lifesciences Launching SAPIEN XT Valve in the U.S.

June 16, 2014

Presentation TVT 2014

Stroke Basics after Cardiovascular Interventions: VARC 2 Definitions, Stroke Severity Assessment, Neuroimaging, and Neurocognitive Function

Presenter: Martin B. Leon

June 07, 2014

Presentation TVT 2014

An Update of New Aortic Valvuloplasty and Valve Remodeling Technologies

Presenter: Martin B. Leon

June 06, 2014

Presentation TVT 2014

The Valve Medical TAVR System

Presenter: Martin B. Leon

June 06, 2014

Presentation TVT 2014

Perspectives on the 5 "Hottest" Topics in TAVR for 2014

Presenter: Martin B. Leon

June 05, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Industry News

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 14, 2014

News Industry News

Tryton Medical Announces Events at EuroPCR 2014 in Paris

May 12, 2014

Presentation CTO 2014

Dedicated Bifurcation Stents in Left Main Disease: Do the Data Support Their Need?

Presenter: Martin B. Leon

March 01, 2014

News Industry News

Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the SENTINEL™ Cerebral Protection System

February 17, 2014

News Daily News

PARTNER: 外科手术与TAVR相比, 出血情况更普遍、更危险

Yael L. Maxwell

January 01, 2014

News Daily News

PARTNER: Hemorragias Más Prevalentes y Peligrosas con la Cirugía que con la TAVR

Yael L. Maxwell

January 01, 2014

News Daily News

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Yael L. Maxwell

January 01, 2014

Presentation

TCT at 25 Years: Lessons Learned and Future Challenges

Presenter: Martin B. Leon

December 02, 2013

Presentation

TAVI Complications: The Current Status

Presenter: Martin B. Leon

December 02, 2013

Presentation

Results of the Elixir DESolve Nx Bioresorbable Coronary Scaffold: Six-Months and One-Year Clinical and Imaging Results

Presenter: Martin B. Leon

December 02, 2013

Presentation

Innovation in Interventional Cardiology: The Next Decade

Presenter: Martin B. Leon

December 02, 2013

News Industry News

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

November 24, 2013

Advertisement

Denervación Renal 2.0: Marcando el Camino de la Recuperación Tras el Symplicity HTN-3

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

Edwards Lifesciences Launching SAPIEN XT Valve in the U.S.

Stroke Basics after Cardiovascular Interventions: VARC 2 Definitions, Stroke Severity Assessment, Neuroimaging, and Neurocognitive Function

An Update of New Aortic Valvuloplasty and Valve Remodeling Technologies

The Valve Medical TAVR System

Perspectives on the 5 "Hottest" Topics in TAVR for 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

Tryton Medical Announces Events at EuroPCR 2014 in Paris

Dedicated Bifurcation Stents in Left Main Disease: Do the Data Support Their Need?

Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the SENTINEL™ Cerebral Protection System

PARTNER: 外科手术与TAVR相比, 出血情况更普遍、更危险

PARTNER: Hemorragias Más Prevalentes y Peligrosas con la Cirugía que con la TAVR

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

TCT at 25 Years: Lessons Learned and Future Challenges

TAVI Complications: The Current Status

Results of the Elixir DESolve Nx Bioresorbable Coronary Scaffold: Six-Months and One-Year Clinical and Imaging Results

Innovation in Interventional Cardiology: The Next Decade

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content